Among a small cohort of healthy Korean male volunteers, evogliptin combined with empagliflozin or dapagliflozin had no significant effects on the pharmacokinetics (PK) of each drug. In healthy male ...
ZENITH-CKD is the first randomized trial comparing combined SGLT2 and endothelin A inhibition in patients with chronic kidney disease. Zibotentan, a selective endothelin A receptor antagonist, may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results